Medical Developments International Ltd (ASX: MVP) Share Price and News

Price
Movement
52 Week Range
1 Year Return
() Chart and Price Data
Fundamental Company Figures
Data provided by Morningstar.Medical Developments International Ltd (ASX: MVP) Latest News
This small cap ASX healthcare share is racing higher following a coronavirus update
James Mickleboro | March 17, 2020 12:15pm
Why this ASX healthcare share has risen over 200% in the past year
Phil Harpur | March 13, 2020 9:56am
Medical Developments International share price lower on shock CEO exit
James Mickleboro | March 5, 2020 10:14am
Why are Medical Developments shares crashing 11% lower today?
Phil Harpur | February 24, 2020 3:59pm
Medical Developments shares move higher on strong earnings release
Phil Harpur | February 19, 2020 3:45pm
3 ASX healthcare growth shares to add to your 2020 watchlist
Rhys Brock | February 18, 2020 12:37pm
Dividend Payment History
Data provided by Morningstar.Ex-Date | Amount | Franking | Type | Payable |
---|---|---|---|---|
05 Mar 2020 | $0.0200 | 100.00% | Interim | 17 Apr 2020 |
03 Sep 2019 | $0.0200 | 100.00% | Final | 04 Oct 2019 |
07 Mar 2019 | $0.0200 | 100.00% | Interim | 17 Apr 2019 |
30 Aug 2018 | $0.0200 | 100.00% | Final | 05 Oct 2018 |
02 Mar 2018 | $0.0200 | 100.00% | Interim | 13 Apr 2018 |
31 Aug 2017 | $0.0200 | 100.00% | Final | 06 Oct 2017 |
03 Mar 2017 | $0.0200 | 100.00% | Interim | 10 Apr 2017 |
01 Sep 2016 | $0.0200 | 100.00% | Final | 07 Oct 2016 |
02 Mar 2016 | $0.0200 | 100.00% | Interim | 08 Apr 2016 |
02 Sep 2013 | $0.0200 | 100.00% | Final | 11 Oct 2013 |
27 Feb 2013 | $0.0300 | 100.00% | Interim | 11 Apr 2013 |
28 Feb 2012 | $0.0300 | 100.00% | Interim | 11 Apr 2012 |
31 Aug 2011 | $0.0300 | 100.00% | Final | 10 Oct 2011 |
Yearly Dividend Payment Chart
Data provided by Morningstar.About Medical Developments International Ltd (ASX: MVP)
Medical Developments International Ltd is a specialized healthcare company. It manufactures and distributes the pharmaceutical drug and medical and veterinary equipment. The company provides a range of products in the areas of pain management, asthma, and resuscitation, plus veterinary equipment. It is organized into three business units: Pharmaceuticals, Medical Devices, and Veterinary products. Majority of its revenue comes from Pharmaceuticals Unit which engages in the sale of Penthrox primarily within Australia, New Zealand, Europe the UK and some sales in Canada, the Middle East, Asia and South Africa.
Share Price History
Data provided by Morningstar.Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
25 Feb 2021 | $5.70 | $0.03 | 0.53% | 67,404 | $5.67 | $5.75 | $5.61 |
24 Feb 2021 | $5.67 | $-0.04 | -0.70% | 81,881 | $5.75 | $5.79 | $5.59 |
23 Feb 2021 | $5.71 | $-0.33 | -5.46% | 152,142 | $6.04 | $6.05 | $5.71 |
22 Feb 2021 | $6.04 | $-0.08 | -1.31% | 69,767 | $6.16 | $6.21 | $6.02 |
19 Feb 2021 | $6.12 | $-0.11 | -1.77% | 50,096 | $6.23 | $6.23 | $6.10 |
18 Feb 2021 | $6.23 | $-0.10 | -1.58% | 41,095 | $6.34 | $6.34 | $6.13 |
17 Feb 2021 | $6.33 | $0.02 | 0.32% | 47,993 | $6.34 | $6.38 | $6.14 |
16 Feb 2021 | $6.31 | $0.12 | 1.94% | 58,403 | $6.17 | $6.32 | $6.10 |
15 Feb 2021 | $6.19 | $0.09 | 1.48% | 83,447 | $6.10 | $6.25 | $6.10 |
12 Feb 2021 | $6.10 | $-0.04 | -0.65% | 50,366 | $6.15 | $6.24 | $6.10 |
11 Feb 2021 | $6.14 | $-0.02 | -0.32% | 46,536 | $6.16 | $6.20 | $6.14 |
10 Feb 2021 | $6.16 | $-0.16 | -2.53% | 59,989 | $6.32 | $6.33 | $6.12 |
09 Feb 2021 | $6.32 | $0.10 | 1.61% | 97,712 | $6.22 | $6.39 | $6.14 |
08 Feb 2021 | $6.22 | $-0.27 | -4.16% | 219,840 | $6.50 | $6.55 | $6.06 |
05 Feb 2021 | $6.49 | $0.07 | 1.09% | 34,380 | $6.41 | $6.53 | $6.41 |
04 Feb 2021 | $6.42 | $-0.13 | -1.98% | 64,852 | $6.59 | $6.59 | $6.35 |
03 Feb 2021 | $6.55 | $0.00 | 0.00% | 65,045 | $6.55 | $6.62 | $6.45 |
02 Feb 2021 | $6.55 | $-0.08 | -1.21% | 51,108 | $6.63 | $6.68 | $6.52 |
01 Feb 2021 | $6.63 | $0.02 | 0.30% | 105,837 | $6.53 | $6.64 | $6.35 |
29 Jan 2021 | $6.61 | $-0.19 | -2.79% | 90,160 | $6.80 | $6.91 | $6.59 |
28 Jan 2021 | $6.80 | $-0.13 | -1.88% | 106,565 | $6.88 | $6.90 | $6.70 |
27 Jan 2021 | $6.93 | $-0.14 | -1.98% | 110,288 | $7.15 | $7.19 | $6.90 |
Director Transactions
Data provided by Morningstar.Directors & Management
Data provided by Morningstar.Top Share Holders
Data provided by Morningstar.Name | Shares | Capital |
---|---|---|
Mr David John Williams | 9,650,782 | 14.71% |
HSBC Custody Nominees | 6,685,759 | 10.19% |
J P Morgan Nominees Australia | 4,249,171 | 6.48% |
Citicorp Nominees Pty Limited | 3,319,510 | 5.06% |
Netwealth Investments Limited | 1,620,522 | 2.47% |
Dr Russell Kay Hancock | 1,614,214 | 2.46% |
Sandhurst Trustees | 1,053,413 | 1.61% |
Ubs Nominees | 874,242 | 1.33% |
National Nominees Limited | 712,776 | 1.09% |
Mr Alistair David Strong | 630,000 | 0.96% |
Warbont Nominees Pty Ltd | 532,983 | 0.81% |
Mrs Virgina Catherine Hancock | 518,487 | 0.79% |
Cs Fourth Nominees | 507,331 | 0.77% |
Jj Opperman Superannuation Pty Limited | 300,000 | 0.46% |
Pnsf Pty Ltd | 264,565 | 0.40% |
Mr Michael Clifford Hickling & Mrs Giovanna Hickling | 255,936 | 0.39% |
Imaj Pty Ltd | 253,750 | 0.39% |
Capricorn Investment Partners (Nominees) Pty Ltd | 250,000 | 0.38% |
BNP Paribas Nominees Pty Ltd | 215,940 | 0.33% |
Hollywind Pty Ltd | 200,000 | 0.30% |